nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CYP2E1—liver cancer	0.174	0.503	CbGaD
Phenobarbital—CYP1A1—liver cancer	0.172	0.497	CbGaD
Phenobarbital—ABCC1—Epirubicin—liver cancer	0.0505	0.119	CbGbCtD
Phenobarbital—ABCC3—Doxorubicin—liver cancer	0.0437	0.103	CbGbCtD
Phenobarbital—ABCB11—Doxorubicin—liver cancer	0.0378	0.0894	CbGbCtD
Phenobarbital—CYP1B1—Doxorubicin—liver cancer	0.0378	0.0894	CbGbCtD
Phenobarbital—ABCC2—Sorafenib—liver cancer	0.0327	0.0775	CbGbCtD
Phenobarbital—ABCB11—bile canaliculus—liver cancer	0.0299	0.348	CbGeAlD
Phenobarbital—ABCC1—Doxorubicin—liver cancer	0.0268	0.0635	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0219	0.0517	CbGbCtD
Phenobarbital—CYP3A7—Sorafenib—liver cancer	0.0219	0.0517	CbGbCtD
Phenobarbital—CYP2B6—Sorafenib—liver cancer	0.0208	0.0493	CbGbCtD
Phenobarbital—ABCC2—Doxorubicin—liver cancer	0.0199	0.047	CbGbCtD
Phenobarbital—CYP3A5—Sorafenib—liver cancer	0.0164	0.0388	CbGbCtD
Phenobarbital—CYP2C8—Sorafenib—liver cancer	0.0158	0.0373	CbGbCtD
Phenobarbital—ABCC2—bile canaliculus—liver cancer	0.0152	0.177	CbGeAlD
Phenobarbital—CYP2C19—Sorafenib—liver cancer	0.0132	0.0313	CbGbCtD
Phenobarbital—CYP2B6—Doxorubicin—liver cancer	0.0126	0.0299	CbGbCtD
Phenobarbital—CYP1A2—Sorafenib—liver cancer	0.0122	0.0289	CbGbCtD
Phenobarbital—CYP2C9—Sorafenib—liver cancer	0.011	0.026	CbGbCtD
Phenobarbital—ABCB1—Sorafenib—liver cancer	0.0107	0.0253	CbGbCtD
Phenobarbital—ABCB11—bile duct—liver cancer	0.00934	0.109	CbGeAlD
Phenobarbital—ABCB11—bile—liver cancer	0.00717	0.0837	CbGeAlD
Phenobarbital—ABCB1—Doxorubicin—liver cancer	0.00648	0.0153	CbGbCtD
Phenobarbital—CYP3A4—Sorafenib—liver cancer	0.0064	0.0151	CbGbCtD
Phenobarbital—ABCC3—bile duct—liver cancer	0.00594	0.0693	CbGeAlD
Phenobarbital—ABCC2—bile duct—liver cancer	0.00475	0.0554	CbGeAlD
Phenobarbital—CYP3A4—Doxorubicin—liver cancer	0.00388	0.00918	CbGbCtD
Phenobarbital—ABCC2—bile—liver cancer	0.00365	0.0425	CbGeAlD
Phenobarbital—ABCC3—gall bladder—liver cancer	0.00127	0.0148	CbGeAlD
Phenobarbital—GRIA2—embryo—liver cancer	0.00117	0.0136	CbGeAlD
Phenobarbital—Hypocalcaemia—Sorafenib—liver cancer	0.00091	0.031	CcSEcCtD
Phenobarbital—CYP4A11—liver—liver cancer	0.000906	0.0106	CbGeAlD
Phenobarbital—Dermatitis exfoliative—Sorafenib—liver cancer	0.000641	0.0218	CcSEcCtD
Phenobarbital—CYP2C18—liver—liver cancer	0.0006	0.007	CbGeAlD
Phenobarbital—ABCB11—liver—liver cancer	0.000584	0.00681	CbGeAlD
Phenobarbital—Mood swings—Sorafenib—liver cancer	0.000573	0.0195	CcSEcCtD
Phenobarbital—CYP3A7—liver—liver cancer	0.000571	0.00666	CbGeAlD
Phenobarbital—Body temperature decreased—Epirubicin—liver cancer	0.000549	0.0187	CcSEcCtD
Phenobarbital—Hypothermia—Epirubicin—liver cancer	0.000549	0.0187	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.000545	0.0186	CcSEcCtD
Phenobarbital—Body temperature decreased—Doxorubicin—liver cancer	0.000508	0.0173	CcSEcCtD
Phenobarbital—Hypothermia—Doxorubicin—liver cancer	0.000508	0.0173	CcSEcCtD
Phenobarbital—CYP3A7-CYP3A51P—liver—liver cancer	0.000486	0.00566	CbGeAlD
Phenobarbital—SLCO2A1—liver—liver cancer	0.000484	0.00564	CbGeAlD
Phenobarbital—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.000462	0.0157	CcSEcCtD
Phenobarbital—Renal failure—Sorafenib—liver cancer	0.000458	0.0156	CcSEcCtD
Phenobarbital—Nystagmus—Epirubicin—liver cancer	0.000431	0.0147	CcSEcCtD
Phenobarbital—Blister—Epirubicin—liver cancer	0.000427	0.0146	CcSEcCtD
Phenobarbital—Nystagmus—Doxorubicin—liver cancer	0.000399	0.0136	CcSEcCtD
Phenobarbital—CYP2A6—liver—liver cancer	0.000397	0.00463	CbGeAlD
Phenobarbital—Erythema multiforme—Sorafenib—liver cancer	0.000396	0.0135	CcSEcCtD
Phenobarbital—Blister—Doxorubicin—liver cancer	0.000395	0.0135	CcSEcCtD
Phenobarbital—Necrosis—Epirubicin—liver cancer	0.000392	0.0134	CcSEcCtD
Phenobarbital—ABCC3—liver—liver cancer	0.000372	0.00433	CbGeAlD
Phenobarbital—Liver injury—Epirubicin—liver cancer	0.000366	0.0125	CcSEcCtD
Phenobarbital—Erythema—Sorafenib—liver cancer	0.000364	0.0124	CcSEcCtD
Phenobarbital—Necrosis—Doxorubicin—liver cancer	0.000363	0.0124	CcSEcCtD
Phenobarbital—Delirium—Epirubicin—liver cancer	0.000358	0.0122	CcSEcCtD
Phenobarbital—Extravasation—Epirubicin—liver cancer	0.000353	0.012	CcSEcCtD
Phenobarbital—Liver injury—Doxorubicin—liver cancer	0.000339	0.0115	CcSEcCtD
Phenobarbital—Hypocalcaemia—Epirubicin—liver cancer	0.000336	0.0115	CcSEcCtD
Phenobarbital—Thinking abnormal—Epirubicin—liver cancer	0.000336	0.0115	CcSEcCtD
Phenobarbital—Angioedema—Sorafenib—liver cancer	0.000333	0.0113	CcSEcCtD
Phenobarbital—Delirium—Doxorubicin—liver cancer	0.000331	0.0113	CcSEcCtD
Phenobarbital—Syncope—Sorafenib—liver cancer	0.000327	0.0111	CcSEcCtD
Phenobarbital—Extravasation—Doxorubicin—liver cancer	0.000327	0.0111	CcSEcCtD
Phenobarbital—Loss of consciousness—Sorafenib—liver cancer	0.00032	0.0109	CcSEcCtD
Phenobarbital—Hypocalcaemia—Doxorubicin—liver cancer	0.000311	0.0106	CcSEcCtD
Phenobarbital—Thinking abnormal—Doxorubicin—liver cancer	0.000311	0.0106	CcSEcCtD
Phenobarbital—Myalgia—Sorafenib—liver cancer	0.00031	0.0106	CcSEcCtD
Phenobarbital—Arthralgia—Sorafenib—liver cancer	0.00031	0.0106	CcSEcCtD
Phenobarbital—Hepatocellular injury—Epirubicin—liver cancer	0.000308	0.0105	CcSEcCtD
Phenobarbital—Injection site reaction—Epirubicin—liver cancer	0.000306	0.0104	CcSEcCtD
Phenobarbital—ABCC2—liver—liver cancer	0.000297	0.00346	CbGeAlD
Phenobarbital—Shock—Sorafenib—liver cancer	0.000293	0.00996	CcSEcCtD
Phenobarbital—CYP1B1—liver—liver cancer	0.000291	0.00339	CbGeAlD
Phenobarbital—Hepatocellular injury—Doxorubicin—liver cancer	0.000285	0.00971	CcSEcCtD
Phenobarbital—Injection site reaction—Doxorubicin—liver cancer	0.000283	0.00965	CcSEcCtD
Phenobarbital—Coma—Epirubicin—liver cancer	0.000281	0.00958	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000271	0.00923	CcSEcCtD
Phenobarbital—Mental disability—Epirubicin—liver cancer	0.000267	0.0091	CcSEcCtD
Phenobarbital—ABCC1—liver—liver cancer	0.000262	0.00305	CbGeAlD
Phenobarbital—Coma—Doxorubicin—liver cancer	0.00026	0.00887	CcSEcCtD
Phenobarbital—CYP2C19—liver—liver cancer	0.000255	0.00297	CbGeAlD
Phenobarbital—Constipation—Sorafenib—liver cancer	0.000254	0.00866	CcSEcCtD
Phenobarbital—Pain—Sorafenib—liver cancer	0.000254	0.00866	CcSEcCtD
Phenobarbital—Mental disability—Doxorubicin—liver cancer	0.000247	0.00842	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Epirubicin—liver cancer	0.000237	0.00807	CcSEcCtD
Phenobarbital—Urticaria—Sorafenib—liver cancer	0.000236	0.00804	CcSEcCtD
Phenobarbital—Body temperature increased—Sorafenib—liver cancer	0.000235	0.008	CcSEcCtD
Phenobarbital—Dermatitis bullous—Epirubicin—liver cancer	0.000234	0.00797	CcSEcCtD
Phenobarbital—ABCB1—embryo—liver cancer	0.000231	0.00269	CbGeAlD
Phenobarbital—Lethargy—Epirubicin—liver cancer	0.000228	0.00777	CcSEcCtD
Phenobarbital—CYP2C8—liver—liver cancer	0.000223	0.0026	CbGeAlD
Phenobarbital—Affect lability—Epirubicin—liver cancer	0.00022	0.00749	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000219	0.00747	CcSEcCtD
Phenobarbital—Hypersensitivity—Sorafenib—liver cancer	0.000219	0.00746	CcSEcCtD
Phenobarbital—Dermatitis bullous—Doxorubicin—liver cancer	0.000216	0.00737	CcSEcCtD
Phenobarbital—Mood swings—Epirubicin—liver cancer	0.000212	0.00721	CcSEcCtD
Phenobarbital—Lethargy—Doxorubicin—liver cancer	0.000211	0.00719	CcSEcCtD
Phenobarbital—Ataxia—Epirubicin—liver cancer	0.00021	0.00716	CcSEcCtD
Phenobarbital—CYP1A2—liver—liver cancer	0.000208	0.00243	CbGeAlD
Phenobarbital—CYP1A1—liver—liver cancer	0.000206	0.0024	CbGeAlD
Phenobarbital—Affect lability—Doxorubicin—liver cancer	0.000204	0.00693	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000201	0.00686	CcSEcCtD
Phenobarbital—CYP3A5—liver—liver cancer	0.000201	0.00234	CbGeAlD
Phenobarbital—CYP2B6—liver—liver cancer	0.0002	0.00233	CbGeAlD
Phenobarbital—CYP2C9—liver—liver cancer	0.000198	0.00231	CbGeAlD
Phenobarbital—Dizziness—Sorafenib—liver cancer	0.000197	0.0067	CcSEcCtD
Phenobarbital—Mood swings—Doxorubicin—liver cancer	0.000196	0.00667	CcSEcCtD
Phenobarbital—Ataxia—Doxorubicin—liver cancer	0.000195	0.00662	CcSEcCtD
Phenobarbital—Asthma—Epirubicin—liver cancer	0.000193	0.00658	CcSEcCtD
Phenobarbital—Vomiting—Sorafenib—liver cancer	0.000189	0.00644	CcSEcCtD
Phenobarbital—Rash—Sorafenib—liver cancer	0.000187	0.00638	CcSEcCtD
Phenobarbital—CYP2E1—liver—liver cancer	0.000187	0.00219	CbGeAlD
Phenobarbital—Dermatitis—Sorafenib—liver cancer	0.000187	0.00638	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000186	0.00634	CcSEcCtD
Phenobarbital—Headache—Sorafenib—liver cancer	0.000186	0.00634	CcSEcCtD
Phenobarbital—Asthma—Doxorubicin—liver cancer	0.000179	0.00609	CcSEcCtD
Phenobarbital—Nausea—Sorafenib—liver cancer	0.000177	0.00601	CcSEcCtD
Phenobarbital—Drowsiness—Epirubicin—liver cancer	0.000172	0.00587	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000171	0.00582	CcSEcCtD
Phenobarbital—Renal failure—Epirubicin—liver cancer	0.000169	0.00577	CcSEcCtD
Phenobarbital—Drowsiness—Doxorubicin—liver cancer	0.000159	0.00543	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000158	0.00538	CcSEcCtD
Phenobarbital—Bradycardia—Epirubicin—liver cancer	0.000157	0.00536	CcSEcCtD
Phenobarbital—Renal failure—Doxorubicin—liver cancer	0.000157	0.00534	CcSEcCtD
Phenobarbital—Hepatitis—Epirubicin—liver cancer	0.000155	0.00527	CcSEcCtD
Phenobarbital—CYP3A4—liver—liver cancer	0.000151	0.00176	CbGeAlD
Phenobarbital—Erythema multiforme—Epirubicin—liver cancer	0.000146	0.00498	CcSEcCtD
Phenobarbital—Bradycardia—Doxorubicin—liver cancer	0.000146	0.00496	CcSEcCtD
Phenobarbital—Hepatitis—Doxorubicin—liver cancer	0.000143	0.00487	CcSEcCtD
Phenobarbital—Erythema multiforme—Doxorubicin—liver cancer	0.000135	0.00461	CcSEcCtD
Phenobarbital—Erythema—Epirubicin—liver cancer	0.000135	0.00459	CcSEcCtD
Phenobarbital—Tension—Epirubicin—liver cancer	0.000132	0.0045	CcSEcCtD
Phenobarbital—Nervousness—Epirubicin—liver cancer	0.000131	0.00445	CcSEcCtD
Phenobarbital—Erythema—Doxorubicin—liver cancer	0.000125	0.00424	CcSEcCtD
Phenobarbital—Agitation—Epirubicin—liver cancer	0.000124	0.00421	CcSEcCtD
Phenobarbital—Tension—Doxorubicin—liver cancer	0.000122	0.00416	CcSEcCtD
Phenobarbital—Nervousness—Doxorubicin—liver cancer	0.000121	0.00412	CcSEcCtD
Phenobarbital—Vertigo—Epirubicin—liver cancer	0.000121	0.00412	CcSEcCtD
Phenobarbital—Syncope—Epirubicin—liver cancer	0.000121	0.00411	CcSEcCtD
Phenobarbital—Loss of consciousness—Epirubicin—liver cancer	0.000118	0.00403	CcSEcCtD
Phenobarbital—Myalgia—Epirubicin—liver cancer	0.000115	0.0039	CcSEcCtD
Phenobarbital—Arthralgia—Epirubicin—liver cancer	0.000115	0.0039	CcSEcCtD
Phenobarbital—Agitation—Doxorubicin—liver cancer	0.000114	0.0039	CcSEcCtD
Phenobarbital—Anxiety—Epirubicin—liver cancer	0.000114	0.00389	CcSEcCtD
Phenobarbital—Vertigo—Doxorubicin—liver cancer	0.000112	0.00381	CcSEcCtD
Phenobarbital—Syncope—Doxorubicin—liver cancer	0.000112	0.0038	CcSEcCtD
Phenobarbital—Confusional state—Epirubicin—liver cancer	0.000111	0.00377	CcSEcCtD
Phenobarbital—Loss of consciousness—Doxorubicin—liver cancer	0.000109	0.00373	CcSEcCtD
Phenobarbital—Shock—Epirubicin—liver cancer	0.000108	0.00368	CcSEcCtD
Phenobarbital—ABCB1—liver—liver cancer	0.000107	0.00124	CbGeAlD
Phenobarbital—Arthralgia—Doxorubicin—liver cancer	0.000106	0.00361	CcSEcCtD
Phenobarbital—Myalgia—Doxorubicin—liver cancer	0.000106	0.00361	CcSEcCtD
Phenobarbital—Anxiety—Doxorubicin—liver cancer	0.000106	0.0036	CcSEcCtD
Phenobarbital—Hypotension—Epirubicin—liver cancer	0.000103	0.0035	CcSEcCtD
Phenobarbital—Confusional state—Doxorubicin—liver cancer	0.000103	0.00349	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Epirubicin—liver cancer	0.0001	0.00341	CcSEcCtD
Phenobarbital—Shock—Doxorubicin—liver cancer	0.0001	0.00341	CcSEcCtD
Phenobarbital—Somnolence—Epirubicin—liver cancer	9.77e-05	0.00333	CcSEcCtD
Phenobarbital—Hypotension—Doxorubicin—liver cancer	9.5e-05	0.00324	CcSEcCtD
Phenobarbital—Constipation—Epirubicin—liver cancer	9.4e-05	0.0032	CcSEcCtD
Phenobarbital—Pain—Epirubicin—liver cancer	9.4e-05	0.0032	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Doxorubicin—liver cancer	9.26e-05	0.00315	CcSEcCtD
Phenobarbital—Feeling abnormal—Epirubicin—liver cancer	9.06e-05	0.00308	CcSEcCtD
Phenobarbital—Somnolence—Doxorubicin—liver cancer	9.04e-05	0.00308	CcSEcCtD
Phenobarbital—Urticaria—Epirubicin—liver cancer	8.73e-05	0.00297	CcSEcCtD
Phenobarbital—Constipation—Doxorubicin—liver cancer	8.69e-05	0.00296	CcSEcCtD
Phenobarbital—Pain—Doxorubicin—liver cancer	8.69e-05	0.00296	CcSEcCtD
Phenobarbital—Body temperature increased—Epirubicin—liver cancer	8.69e-05	0.00296	CcSEcCtD
Phenobarbital—Feeling abnormal—Doxorubicin—liver cancer	8.38e-05	0.00285	CcSEcCtD
Phenobarbital—Hypersensitivity—Epirubicin—liver cancer	8.1e-05	0.00276	CcSEcCtD
Phenobarbital—Urticaria—Doxorubicin—liver cancer	8.08e-05	0.00275	CcSEcCtD
Phenobarbital—Body temperature increased—Doxorubicin—liver cancer	8.04e-05	0.00274	CcSEcCtD
Phenobarbital—Hypersensitivity—Doxorubicin—liver cancer	7.49e-05	0.00255	CcSEcCtD
Phenobarbital—Dizziness—Epirubicin—liver cancer	7.27e-05	0.00247	CcSEcCtD
Phenobarbital—Vomiting—Epirubicin—liver cancer	6.99e-05	0.00238	CcSEcCtD
Phenobarbital—Rash—Epirubicin—liver cancer	6.93e-05	0.00236	CcSEcCtD
Phenobarbital—Dermatitis—Epirubicin—liver cancer	6.92e-05	0.00236	CcSEcCtD
Phenobarbital—Headache—Epirubicin—liver cancer	6.88e-05	0.00234	CcSEcCtD
Phenobarbital—Dizziness—Doxorubicin—liver cancer	6.72e-05	0.00229	CcSEcCtD
Phenobarbital—Nausea—Epirubicin—liver cancer	6.53e-05	0.00222	CcSEcCtD
Phenobarbital—Vomiting—Doxorubicin—liver cancer	6.46e-05	0.0022	CcSEcCtD
Phenobarbital—Rash—Doxorubicin—liver cancer	6.41e-05	0.00218	CcSEcCtD
Phenobarbital—Dermatitis—Doxorubicin—liver cancer	6.4e-05	0.00218	CcSEcCtD
Phenobarbital—Headache—Doxorubicin—liver cancer	6.37e-05	0.00217	CcSEcCtD
Phenobarbital—Nausea—Doxorubicin—liver cancer	6.04e-05	0.00206	CcSEcCtD
Phenobarbital—CYP2C9—Metabolism—HPGDS—liver cancer	4.62e-06	3.97e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PIK3CG—liver cancer	4.62e-06	3.97e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PPARG—liver cancer	4.61e-06	3.96e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.6e-06	3.95e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.59e-06	3.95e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NR1H4—liver cancer	4.56e-06	3.92e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—MTHFR—liver cancer	4.54e-06	3.9e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.53e-06	3.9e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CRABP1—liver cancer	4.52e-06	3.88e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PSMD10—liver cancer	4.52e-06	3.88e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PSMA4—liver cancer	4.52e-06	3.88e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—GSTP1—liver cancer	4.51e-06	3.88e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTA3—liver cancer	4.49e-06	3.86e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.48e-06	3.85e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—RAF1—liver cancer	4.47e-06	3.84e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PPARA—liver cancer	4.46e-06	3.83e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PPARG—liver cancer	4.46e-06	3.83e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—HMOX1—liver cancer	4.45e-06	3.82e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—GSTP1—liver cancer	4.42e-06	3.8e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PSMA4—liver cancer	4.41e-06	3.79e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PSMD10—liver cancer	4.41e-06	3.79e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—GSTP1—liver cancer	4.41e-06	3.79e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GOT2—liver cancer	4.4e-06	3.78e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PIK3CB—liver cancer	4.37e-06	3.75e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MTOR—liver cancer	4.37e-06	3.75e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—HMOX1—liver cancer	4.36e-06	3.75e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—HMOX1—liver cancer	4.35e-06	3.74e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CYCS—liver cancer	4.33e-06	3.72e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GOT2—liver cancer	4.29e-06	3.69e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GGT1—liver cancer	4.25e-06	3.65e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GOT1—liver cancer	4.25e-06	3.65e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	4.21e-06	3.62e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PIK3CD—liver cancer	4.2e-06	3.61e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.19e-06	3.6e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—GSTP1—liver cancer	4.17e-06	3.58e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CG—liver cancer	4.16e-06	3.58e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—GSTM1—liver cancer	4.15e-06	3.56e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—ALB—liver cancer	4.14e-06	3.56e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CYP2E1—liver cancer	4.13e-06	3.55e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.13e-06	3.55e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PSMA4—liver cancer	4.12e-06	3.54e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PSMD10—liver cancer	4.12e-06	3.54e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—HMOX1—liver cancer	4.11e-06	3.53e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTA4—liver cancer	4.1e-06	3.53e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CDKN1B—liver cancer	4.1e-06	3.52e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.07e-06	3.5e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—GSTM1—liver cancer	4.06e-06	3.49e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PIK3CD—liver cancer	4.06e-06	3.49e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—GSTM1—liver cancer	4.05e-06	3.48e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CYP2E1—liver cancer	4.04e-06	3.47e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PPARG—liver cancer	4.02e-06	3.45e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GOT2—liver cancer	4.01e-06	3.45e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—ALB—liver cancer	4.01e-06	3.44e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4e-06	3.44e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTA2—liver cancer	4e-06	3.44e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—HPGDS—liver cancer	3.95e-06	3.4e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CYP1A1—liver cancer	3.93e-06	3.38e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.93e-06	3.38e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CTNNB1—liver cancer	3.87e-06	3.33e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CYCS—liver cancer	3.87e-06	3.32e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTA1—liver cancer	3.86e-06	3.32e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CYP1A1—liver cancer	3.85e-06	3.31e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CYP1A1—liver cancer	3.84e-06	3.3e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—GSTM1—liver cancer	3.83e-06	3.29e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GSTP1—liver cancer	3.82e-06	3.28e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CG—liver cancer	3.82e-06	3.28e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NAT2—liver cancer	3.81e-06	3.28e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	3.81e-06	3.27e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GGT1—liver cancer	3.8e-06	3.26e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GOT1—liver cancer	3.8e-06	3.26e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CDKN1A—liver cancer	3.78e-06	3.25e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CYCS—liver cancer	3.78e-06	3.24e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CYP2E1—liver cancer	3.77e-06	3.24e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—HMOX1—liver cancer	3.77e-06	3.24e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GOT1—liver cancer	3.7e-06	3.18e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GGT1—liver cancer	3.7e-06	3.18e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PPARG—liver cancer	3.68e-06	3.16e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—MTHFR—liver cancer	3.66e-06	3.15e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CD—liver cancer	3.66e-06	3.14e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ALDOB—liver cancer	3.66e-06	3.14e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PIK3CB—liver cancer	3.66e-06	3.14e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.65e-06	3.14e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—ALB—liver cancer	3.61e-06	3.1e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PPARA—liver cancer	3.6e-06	3.09e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—MTHFR—liver cancer	3.59e-06	3.08e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—MTHFR—liver cancer	3.58e-06	3.08e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.58e-06	3.07e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PIK3CB—liver cancer	3.54e-06	3.04e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.53e-06	3.04e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CYCS—liver cancer	3.53e-06	3.03e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PSMD10—liver cancer	3.52e-06	3.03e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PSMA4—liver cancer	3.52e-06	3.03e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PPARA—liver cancer	3.52e-06	3.03e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PPARA—liver cancer	3.51e-06	3.02e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GSTM1—liver cancer	3.51e-06	3.02e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CRABP1—liver cancer	3.49e-06	3e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GGT1—liver cancer	3.46e-06	2.97e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GOT1—liver cancer	3.46e-06	2.97e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GOT2—liver cancer	3.43e-06	2.94e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GSTP1—liver cancer	3.41e-06	2.93e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—MTHFR—liver cancer	3.38e-06	2.91e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—STAT3—liver cancer	3.38e-06	2.9e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—HMOX1—liver cancer	3.36e-06	2.89e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CD—liver cancer	3.35e-06	2.88e-05	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—PIK3CA—liver cancer	3.35e-06	2.88e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GSTP1—liver cancer	3.33e-06	2.86e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CYP1A1—liver cancer	3.33e-06	2.86e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PPARA—liver cancer	3.32e-06	2.85e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—ALB—liver cancer	3.31e-06	2.85e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—HMOX1—liver cancer	3.28e-06	2.82e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYP2E1—liver cancer	3.22e-06	2.77e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CB—liver cancer	3.19e-06	2.74e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MYC—liver cancer	3.14e-06	2.69e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GSTM1—liver cancer	3.13e-06	2.69e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—TGFB1—liver cancer	3.13e-06	2.69e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.12e-06	2.68e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GSTP1—liver cancer	3.11e-06	2.67e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—MTHFR—liver cancer	3.1e-06	2.67e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CG—liver cancer	3.08e-06	2.65e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—HMOX1—liver cancer	3.07e-06	2.63e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GSTM1—liver cancer	3.06e-06	2.63e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—HPGDS—liver cancer	3.05e-06	2.62e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PPARA—liver cancer	3.04e-06	2.62e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CG—liver cancer	3.02e-06	2.59e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYCS—liver cancer	3.01e-06	2.59e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CG—liver cancer	3.01e-06	2.59e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.98e-06	2.56e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PPARG—liver cancer	2.97e-06	2.55e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CYP1A1—liver cancer	2.97e-06	2.55e-05	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PIK3CA—liver cancer	2.97e-06	2.55e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GOT1—liver cancer	2.96e-06	2.54e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GGT1—liver cancer	2.96e-06	2.54e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PIK3CA—liver cancer	2.93e-06	2.51e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CB—liver cancer	2.92e-06	2.51e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PPARG—liver cancer	2.91e-06	2.5e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PPARG—liver cancer	2.9e-06	2.5e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CYP1A1—liver cancer	2.9e-06	2.49e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—KRAS—liver cancer	2.9e-06	2.49e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GSTM1—liver cancer	2.86e-06	2.45e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PIK3CA—liver cancer	2.85e-06	2.44e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CG—liver cancer	2.84e-06	2.44e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—MTHFR—liver cancer	2.77e-06	2.38e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PPARG—liver cancer	2.74e-06	2.36e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.73e-06	2.35e-05	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—AKT1—liver cancer	2.73e-06	2.35e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PSMA4—liver cancer	2.72e-06	2.34e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PSMD10—liver cancer	2.72e-06	2.34e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PPARA—liver cancer	2.72e-06	2.33e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CYP1A1—liver cancer	2.71e-06	2.33e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CD—liver cancer	2.71e-06	2.33e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—MTHFR—liver cancer	2.7e-06	2.32e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—ALB—liver cancer	2.67e-06	2.3e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PIK3CA—liver cancer	2.66e-06	2.29e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTP1—liver cancer	2.66e-06	2.28e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PPARA—liver cancer	2.65e-06	2.28e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CD—liver cancer	2.65e-06	2.28e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CD—liver cancer	2.65e-06	2.27e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GOT2—liver cancer	2.64e-06	2.27e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—HMOX1—liver cancer	2.62e-06	2.25e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—ALB—liver cancer	2.62e-06	2.25e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—ALB—liver cancer	2.61e-06	2.24e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CG—liver cancer	2.61e-06	2.24e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—MTHFR—liver cancer	2.52e-06	2.17e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PPARG—liver cancer	2.52e-06	2.16e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CD—liver cancer	2.5e-06	2.15e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP2E1—liver cancer	2.49e-06	2.14e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PPARA—liver cancer	2.48e-06	2.13e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—ALB—liver cancer	2.47e-06	2.12e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—HRAS—liver cancer	2.46e-06	2.12e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTM1—liver cancer	2.44e-06	2.1e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.44e-06	2.1e-05	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—AKT1—liver cancer	2.42e-06	2.08e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—AKT1—liver cancer	2.39e-06	2.05e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CB—liver cancer	2.36e-06	2.03e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—IL6—liver cancer	2.36e-06	2.03e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CG—liver cancer	2.33e-06	2e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYCS—liver cancer	2.33e-06	2e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—AKT1—liver cancer	2.32e-06	2e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYP1A1—liver cancer	2.31e-06	1.99e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CB—liver cancer	2.31e-06	1.99e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CB—liver cancer	2.31e-06	1.98e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CD—liver cancer	2.29e-06	1.97e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GOT1—liver cancer	2.28e-06	1.96e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GGT1—liver cancer	2.28e-06	1.96e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CG—liver cancer	2.27e-06	1.95e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—ALB—liver cancer	2.26e-06	1.94e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PPARG—liver cancer	2.25e-06	1.93e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PIK3CA—liver cancer	2.23e-06	1.92e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.23e-06	1.91e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PPARG—liver cancer	2.19e-06	1.88e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CB—liver cancer	2.18e-06	1.87e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—AKT1—liver cancer	2.17e-06	1.87e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—MTHFR—liver cancer	2.16e-06	1.85e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PIK3CA—liver cancer	2.16e-06	1.85e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CG—liver cancer	2.12e-06	1.82e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PPARA—liver cancer	2.12e-06	1.82e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTP1—liver cancer	2.05e-06	1.76e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PPARG—liver cancer	2.05e-06	1.76e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CD—liver cancer	2.05e-06	1.76e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—HMOX1—liver cancer	2.02e-06	1.74e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—ALB—liver cancer	2.02e-06	1.73e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CB—liver cancer	2e-06	1.72e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CD—liver cancer	2e-06	1.72e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—ALB—liver cancer	1.97e-06	1.69e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CA—liver cancer	1.94e-06	1.67e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.9e-06	1.63e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTM1—liver cancer	1.88e-06	1.62e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CD—liver cancer	1.86e-06	1.6e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—ALB—liver cancer	1.84e-06	1.58e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—AKT1—liver cancer	1.82e-06	1.57e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CG—liver cancer	1.81e-06	1.56e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP1A1—liver cancer	1.79e-06	1.53e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CB—liver cancer	1.78e-06	1.53e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CA—liver cancer	1.78e-06	1.53e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—AKT1—liver cancer	1.76e-06	1.51e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PPARG—liver cancer	1.75e-06	1.5e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CB—liver cancer	1.74e-06	1.5e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—MTHFR—liver cancer	1.67e-06	1.43e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PPARA—liver cancer	1.63e-06	1.4e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CB—liver cancer	1.63e-06	1.4e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CD—liver cancer	1.59e-06	1.37e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—AKT1—liver cancer	1.59e-06	1.37e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ALB—liver cancer	1.57e-06	1.35e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—AKT1—liver cancer	1.46e-06	1.25e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CA—liver cancer	1.44e-06	1.24e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CA—liver cancer	1.41e-06	1.21e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CA—liver cancer	1.41e-06	1.21e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CG—liver cancer	1.4e-06	1.2e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CB—liver cancer	1.39e-06	1.19e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PPARG—liver cancer	1.35e-06	1.16e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CA—liver cancer	1.33e-06	1.14e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CD—liver cancer	1.23e-06	1.06e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CA—liver cancer	1.22e-06	1.05e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ALB—liver cancer	1.21e-06	1.04e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—AKT1—liver cancer	1.17e-06	1.01e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—AKT1—liver cancer	1.15e-06	9.89e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—AKT1—liver cancer	1.15e-06	9.87e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CA—liver cancer	1.09e-06	9.34e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—AKT1—liver cancer	1.08e-06	9.32e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CB—liver cancer	1.07e-06	9.21e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CA—liver cancer	1.06e-06	9.11e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—AKT1—liver cancer	9.95e-07	8.55e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CA—liver cancer	9.91e-07	8.51e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—AKT1—liver cancer	8.88e-07	7.63e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—AKT1—liver cancer	8.67e-07	7.45e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CA—liver cancer	8.47e-07	7.28e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—AKT1—liver cancer	8.1e-07	6.96e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—AKT1—liver cancer	6.92e-07	5.94e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CA—liver cancer	6.54e-07	5.62e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—AKT1—liver cancer	5.34e-07	4.59e-06	CbGpPWpGaD
